| abstract |
FIELD: medicine, pharmaceutics. n SUBSTANCE: invention refers to medicine and pharmaceutical industry, namely a combination of clopidogrel and ethylmethylhydroxypyridine. A composition on the basis of the combination is presented in the form of a solid pharmaceutical composition, namely in the form of capsules. n EFFECT: composition of clopidogrel and ethylmethylhydroxypyridine is promising for prevention and treatment of obesity, pathological cardiovascular conditions prevention of ischemic disorders with manifested atherosclerosis, suffered infarction, ischemic stroke, peripheral arterial disease. n 2 cl, 2 tbl |